These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8492116)

  • 1. Brain purines in a genetic mouse model of Lesch-Nyhan disease.
    Jinnah HA; Page T; Friedmann T
    J Neurochem; 1993 Jun; 60(6):2036-45. PubMed ID: 8492116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine synthesis de novo and salvage in hypoxanthine phosphoribosyltransferase-deficient mice.
    Allsop J; Watts RW
    Enzyme; 1990; 43(3):155-9. PubMed ID: 2095336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch-Nyhan syndrome.
    Bakay B; Nissinen E; Sweetman L; Francke U; Nyhan WL
    Pediatr Res; 1979 Dec; 13(12):1365-70. PubMed ID: 523196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
    Jinnah HA; Langlais PJ; Friedmann T
    J Pharmacol Exp Ther; 1992 Nov; 263(2):596-607. PubMed ID: 1432691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human neuronal tissue culture model for Lesch-Nyhan disease.
    Shirley TL; Lewers JC; Egami K; Majumdar A; Kelly M; Ceballos-Picot I; Seidman MM; Jinnah HA
    J Neurochem; 2007 May; 101(3):841-53. PubMed ID: 17448149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.
    Edwards NL; Recker D; Fox IH
    J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.
    Fu R; Sutcliffe D; Zhao H; Huang X; Schretlen DJ; Benkovic S; Jinnah HA
    Mol Genet Metab; 2015 Jan; 114(1):55-61. PubMed ID: 25481104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.
    Kuehn MR; Bradley A; Robertson EJ; Evans MJ
    Nature; 1987 Mar 19-25; 326(6110):295-8. PubMed ID: 3029599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine metabolism in female heterozygotes for hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Puig JG; Mateos FA; Torres RJ; Buño AS
    Eur J Clin Invest; 1998 Nov; 28(11):950-7. PubMed ID: 9824441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesch-Nyhan syndrome: mRNA expression of HPRT in patients with enzyme proven deficiency of HPRT and normal HPRT coding region of the DNA.
    Nguyen KV; Naviaux RK; Paik KK; Nyhan WL
    Mol Genet Metab; 2012 Aug; 106(4):498-501. PubMed ID: 22766437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD metabolism in HPRT-deficient mice.
    Micheli V; Jacomelli G; Di Marcello F; Notarantonio L; Sestini S; Cerboni B; Bertelli M; Pompucci G; Jinnah HA
    Metab Brain Dis; 2009 Jun; 24(2):311-9. PubMed ID: 19319672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesized deficiency of guanine-based purines may contribute to abnormalities of neurodevelopment, neuromodulation, and neurotransmission in Lesch-Nyhan syndrome.
    Deutsch SI; Long KD; Rosse RB; Mastropaolo J; Eller J
    Clin Neuropharmacol; 2005; 28(1):28-37. PubMed ID: 15711436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in human HPRT and its relationship to neurologic and behavioral manifestations.
    Bakay B; Nissinen E; Sweetman L; Francke U; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():317-25. PubMed ID: 7424650
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired differentiation of HPRT-deficient dopaminergic neurons: a possible mechanism underlying neuronal dysfunction in Lesch-Nyhan syndrome.
    Yeh J; Zheng S; Howard BD
    J Neurosci Res; 1998 Jul; 53(1):78-85. PubMed ID: 9670994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.
    Jinnah HA; Wojcik BE; Hunt M; Narang N; Lee KY; Goldstein M; Wamsley JK; Langlais PJ; Friedmann T
    J Neurosci; 1994 Mar; 14(3 Pt 1):1164-75. PubMed ID: 7509865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families.
    Puig JG; Torres RJ; Mateos FA; Ramos TH; Arcas JM; Buño AS; O'Neill P
    Medicine (Baltimore); 2001 Mar; 80(2):102-12. PubMed ID: 11307586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and urine with metabolite profiles in CSF.
    Harkness RA; McCreanor GM; Watts RW
    J Inherit Metab Dis; 1988; 11(3):239-52. PubMed ID: 3148065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line.
    Tohyama J; Nanba E; Ohno K
    Hum Genet; 1994 Feb; 93(2):175-81. PubMed ID: 8112742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced levels of dopamine and altered metabolism in brains of HPRT knock-out rats: a new rodent model of Lesch-Nyhan Disease.
    Meek S; Thomson AJ; Sutherland L; Sharp MG; Thomson J; Bishop V; Meddle SL; Gloaguen Y; Weidt S; Singh-Dolt K; Buehr M; Brown HK; Gill AC; Burdon T
    Sci Rep; 2016 May; 6():25592. PubMed ID: 27185277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.